Do Mammograms Damage Breast Tissue? A Scientific Look

Standard mammography uses low-dose X-rays and breast compression, both of which produce measurable biological effects on tissue, but the scale of those effects is far smaller than most people fear. The radiation dose from a single screening mammogram sits in the range of about 2 to 5 milligray, and the compression, while sometimes painful, rarely causes lasting physical harm. The question is genuinely more layered than a simple yes or no, because “damage” can mean anything from temporary soreness to DNA strand breaks to a theoretical increase in cancer risk decades later.

What Compression Does to Breast Tissue

During a mammogram, two flat plates squeeze the breast to spread the tissue into a thinner, more uniform layer. This serves two purposes: it improves image quality by separating overlapping structures, and it reduces the radiation dose needed to produce a clear image because X-rays travel through less tissue.¹ In Norway’s national screening program, the recommended compression force ranges from about 108 to 177 newtons, which translates to roughly 11 to 18 kilograms of pressure.² That is a substantial squeeze, and it is no surprise that many women find it uncomfortable or outright painful.

For the vast majority of women, the discomfort is temporary. The tissue springs back, and there is no lasting structural change. In rare cases, though, compression can cause a hematoma, which is essentially a pocket of blood from a burst vessel inside the breast. One published case involved a woman who developed intense persistent pain, swelling, and a hematoma after a routine mammogram; three months later, imaging revealed a large mass in the same area that turned out to be a high-grade cancer.³ That case raised uncomfortable questions about whether the compression might have disrupted a pre-existing but undetected tumor, but a single case report cannot establish causation. It is the kind of finding that gets attention precisely because it is so unusual.

Does Compression Spread Existing Tumors?

One of the more persistent fears is that squeezing a breast containing an undiagnosed cancer could dislodge tumor cells and push them into the bloodstream. Researchers have tested this directly by measuring circulating tumor cells in women with known breast cancers before and after mammographic compression. In one study, about 17 percent of participants had detectable circulating tumor cells before compression, and the numbers did not increase afterward. No relationship was found between the applied pressure and the presence of circulating tumor cells.⁴ The evidence here is reassuring: compression does not appear to squeeze cancer cells out of a tumor and into circulation.

How Much Radiation You Actually Receive

Mammography uses X-rays, and X-rays are ionizing radiation, meaning they carry enough energy to knock electrons off atoms and break chemical bonds in DNA. The dose, however, is quite low. A standard two-view digital mammogram delivers roughly 2 to 6 milligray to the breast, depending on breast thickness and density. For context, that is a fraction of the roughly 3 milligray of background radiation the average person absorbs from natural sources every year.

Modern digital systems deliver meaningfully less radiation than the older film-based machines they replaced. Digital breast tomosynthesis, sometimes called 3D mammography, takes multiple low-dose images from different angles. When used alone, tomosynthesis can deliver a dose comparable to or lower than standard digital mammography. But when a facility combines tomosynthesis with a conventional digital mammogram in the same visit, the total dose roughly doubles.⁵ A clinical study comparing the two techniques found that tomosynthesis alone consistently delivered lower median doses across all breast thicknesses compared to standard digital mammography.⁶ European guidelines set an upper limit of 2.5 milligray for a standard breast, and most modern centers fall within that range.⁷

DNA Damage at Mammography Doses

Here is where the picture gets more interesting, and where the honest answer is not entirely comforting. Even at the very low doses used in mammography, X-rays do cause measurable DNA damage. Researchers can see this by counting a specific marker called gamma-H2AX foci, which light up at the sites of DNA double-strand breaks. In one study, blood samples irradiated at mammography-level doses (around 2.5 to 3 milligray) showed a statistically significant increase in these damage markers compared to unirradiated controls. Women who underwent actual tomosynthesis imaging showed the same pattern: their post-scan blood samples had roughly 60 percent more damage markers than pre-scan samples.⁸

A separate pilot study irradiated freshly removed healthy breast tissue with mammography-type X-rays and found something unexpected: the dose-response curve was not a straight line. In the very low dose range representative of screening mammography (under 20 milligray), the rate of DNA double-strand breaks per unit dose was nearly nine times steeper than it was at higher doses.⁹ The researchers attributed this to a biological phenomenon where nearby unirradiated cells respond to signals from damaged neighbors, amplifying the effect. This suggests that per milligray, the very low doses used in mammography may be more biologically potent than the same dose would be in a higher-dose context.

That finding is worth sitting with for a moment, because it complicates the standard reassurance that “the dose is so low it doesn’t matter.” The dose is low, yes. But the cells’ response to it is not proportionally low. The body has robust DNA repair mechanisms that handle most of this damage within hours, but these studies found residual damage markers persisting up to 72 hours after exposure.⁸ That does not mean the damage is permanent or that it will lead to cancer, but it does mean the interaction between mammography radiation and breast cells is more complex than a simple “too low to cause harm” framing suggests.

Putting the Radiation Risk in Numbers

The question that matters most to a person weighing whether to get screened is not “does mammography cause DNA damage?” (it does) but “how does the tiny radiation risk compare to the benefit of catching cancer early?” Modeling studies have tried to quantify this tradeoff, and the numbers are striking in how lopsided they are in favor of screening.

One widely cited model projected that annual screening of 100,000 women aged 40 to 74 would induce about 125 breast cancers and lead to roughly 16 radiation-attributable deaths over a lifetime. Set against that, the same screening program was projected to avert 968 breast cancer deaths through early detection, a ratio of about 60 lives saved for every one lost to radiation-induced cancer.¹⁰ Switching to biennial screening starting at age 50 instead of annual screening from age 40 reduced the radiation-induced cancer risk roughly fivefold.¹⁰

A more recent model using individual-level dose tracking estimated that biennial screening from age 50 to 74 would cause between about 9 and 15 radiation-induced breast cancers per 100,000 women, depending on whether the woman fell into a low, medium, or high dose category.¹¹ Those numbers are not zero, but they are small enough that the early-detection benefit overwhelms them for most women.

Why Breast Size and Age Change the Equation

Not every woman gets the same dose from a mammogram. Larger breasts require more radiation to produce a clear image, and they sometimes need extra views to capture the full volume of tissue. The modeling study mentioned above found that women with large breasts requiring additional views (about 8 percent of the screened population) were projected to develop more than twice as many radiation-induced breast cancers as women with small or average breasts: 266 versus 113 per 100,000 women over a lifetime of annual screening.¹⁰

Age matters too, and it cuts in a less intuitive direction. Younger breast tissue is more sensitive to radiation than older tissue. A study of mammography doses in Dubai found that the lifetime attributable risk of radiation-induced cancer decreased with age across all breast thickness categories, with the highest initial risk values seen in younger women with thicker breast tissue.¹² This is one reason why screening guidelines in many countries start at 40 or 50 rather than earlier: the radiation risk is relatively higher in younger women, while the absolute likelihood of having breast cancer to detect is lower.

BRCA Mutation Carriers and Heightened Radiation Sensitivity

BRCA1 and BRCA2 genes play a central role in DNA repair. Women who carry mutations in these genes already face a significantly elevated lifetime breast cancer risk, and there is real concern that their cells may also be worse at repairing the DNA damage caused by mammography radiation. Laboratory research supports this worry. When breast cells from BRCA mutation carriers were exposed to the low, repeated doses that simulate a two-view mammogram (two doses of about 2 milligray given three minutes apart), they showed more DNA double-strand breaks than expected from simply adding the two doses together. This supra-additive effect was more pronounced in high-risk women than in average-risk controls.¹³

Separate research found that mammography-level X-ray doses induced chromosomal instability in cells from BRCA mutation carriers, producing the same kinds of gross chromosomal rearrangements seen in actual breast cancer cells. The researchers went as far as suggesting that early and frequent mammographic screening may not be the optimal detection method for these women.¹⁴ This is why clinical guidelines for BRCA carriers increasingly recommend MRI as the primary screening tool, since MRI uses magnetic fields and radio waves rather than ionizing radiation. Mammography may still be used alongside MRI in these women, but the calculus around its radiation risk is genuinely different for them than for the general population.

What About Breast Implants?

Women with breast implants sometimes worry that the compression during mammography could rupture or damage their implants. The technique is slightly modified for implant patients: the technologist typically uses what is called implant displacement views, pushing the implant back and pulling the breast tissue forward to image it more effectively. Compression is still applied, but with awareness of the implant’s position. An analysis of the FDA’s adverse event database found that while implant rupture, pain, changes in implant appearance, and swelling were reported, the overall rate of implant-related adverse events during mammography was extremely low. The researchers concluded that the risk should neither prevent women with implants from getting screened nor discourage anyone from getting implants in the first place.¹⁵

Compression, Density, and Screening Accuracy

There is a less obvious way that compression interacts with breast tissue: it affects how dense the breast appears on the image, and that in turn affects how accurately the mammogram can detect cancer. A large population-based study found that as compression pressure increased, the breast volume decreased (as expected), but the percent dense volume actually went up. Counterintuitively, sensitivity, meaning the test’s ability to catch real cancers, dropped at the highest compression pressures. Women in the highest pressure group had a sensitivity of about 71 percent for cancers detected within 12 months, compared to roughly 94 percent in the middle pressure group.¹⁶ Too much compression, it turns out, can actually make the image harder to read, not easier.

This is a nuance that most patients never hear about. The assumption is that more compression equals better images, but there appears to be a sweet spot. Below it, the tissue is too thick and overlapping for a clean image. Above it, the tissue gets so compressed that dense structures blur together and specificity or sensitivity drops. Finding that middle ground is part of the technologist’s skill.

Pain and the Question of Whether It Keeps Women From Screening

Somewhere between a quarter and nearly half of women cite pain during compression as a primary reason for avoiding future mammograms.¹⁷ That range is wide, but even the low end represents a significant number of women potentially missing life-saving screening because of discomfort. This is a real public health problem, and the imaging community has been working on it.

One approach is redesigning the compression paddle itself. A flexible paddle, which tilts to distribute pressure more evenly across the breast, has been compared to the traditional rigid paddle in clinical trials. One study found that about a third of women experienced moderate to severe discomfort with either paddle type, with no significant difference in pain scores between the two designs.¹⁸ A more recent three-way comparison, however, did find a benefit for the flexible paddle: women reported lower average pain scores with it, and the risk of severe pain was roughly half that of the fixed paddle.¹⁹ The results are mixed enough that no single paddle design has become the universal standard, but the trend is toward equipment that adapts to the breast’s shape rather than treating it as a uniform block.

Fat Necrosis and Trauma-Related Breast Changes

Fat necrosis, where fatty breast tissue dies and sometimes forms a lump or cyst, is a well-known consequence of breast trauma. Car accidents, seat belt injuries, and surgical procedures are the most common causes. Mammographic compression has occasionally been discussed as a potential trigger, though documented cases are scarce. The lumps produced by fat necrosis can mimic cancer on imaging, which sometimes leads to unnecessary biopsies and significant patient anxiety. In rare cases, fat necrosis produces oil cysts that can grow over many years; one reported case involved a cyst that first appeared after a car accident and continued expanding for over a decade.²⁰ The relevance to mammography is that any significant breast trauma can theoretically set off this chain of events, but the compression forces used in screening are far below those involved in motor vehicle collisions or surgery.

If you develop a new lump or persistent pain after a mammogram, it is worth getting it evaluated. But the likelihood that screening-level compression caused structural fat necrosis is very low. The more common aftermath is simple bruising or soreness that resolves within a few days.

How Screening Protocols Manage the Risk

The fact that mammography does carry a real, if tiny, radiation risk is not something the medical community ignores. It is baked into the design of screening guidelines. The recommendation in many countries to screen biennially rather than annually after age 50, for instance, directly reflects the desire to minimize cumulative radiation exposure while preserving most of the early-detection benefit. As noted earlier, switching from annual to biennial screening can reduce the projected number of radiation-induced cancers roughly fivefold.

Equipment standards also play a role. Mammography machines are subject to strict regulatory limits on the dose they can deliver per image. Facilities undergo regular quality assurance testing. The shift from film to digital systems brought a meaningful dose reduction, and the continued development of tomosynthesis and synthetic 2D imaging (where a computer reconstructs a standard mammogram image from the 3D dataset, eliminating the need for a separate 2D exposure) promises to shrink the dose further. The trend line in mammographic dose has been consistently downward for decades, and there is no reason to expect it to reverse.

For the average woman at average risk, the current evidence overwhelmingly supports screening mammography as a net positive. The DNA damage is real but mostly repaired, the radiation risk is quantifiable but dwarfed by the detection benefit, and the compression, while uncomfortable, does not cause lasting tissue harm in the vast majority of cases. The picture is more nuanced for specific groups like BRCA carriers, where alternative imaging modalities deserve serious consideration, and for younger women, where the radiation sensitivity of breast tissue tips the risk-benefit calculation enough to justify delaying the start of routine screening.